TKTX
Transkaryotic Therapies Inc
Biotechnology company developing enzyme replacement therapies for rare diseases, including Replagal for Fabry disease
CUSIP: 893735100HealthcareUS1 holder
Transkaryotic Therapies Inc
Biotechnology company developing enzyme replacement therapies for rare diseases, including Replagal for Fabry disease
No insider transactions reported in the last year. Look across all recorded history →